Navigation Links
Einstein researchers find key gene in childhood cancer
Date:5/5/2011

May 5, 2011 (BRONX, NY) There are no effective treatments for rhabdoid tumors aggressive childhood cancers that usually strike children under three years old and affect the brain or kidneys. The disease is extremely rare fewer than 10 cases are diagnosed each year in the U.S. but is particularly difficult to treat and almost always fatal.

Now scientists at Albert Einstein College of Medicine of Yeshiva University have identified a target for potential therapies for these tumors: a gene called Aurora A that is vital for tumor growth. The research team was led by Ganjam Kalpana, Ph.D., professor of genetics and of microbiology & immunology, the Mark Trauner Faculty Scholar in Neuro-oncology at Einstein. Their findings appear in the April 26 online issue of Cancer Research.

The Aurora A gene is known to be expressed at higher-than-normal levels in many cancers, and its expression is associated with poor prognosis. Scientists have also known that mutations in a tumor suppressor gene called INI1/hSNF5 can lead to rhabdoid tumors. In this study, the Kalpana team found that, in rhabdoid tumors, loss of the tumor suppressor gene INI1/hSNF5 leads to changes in Aurora A's expression that are crucial for tumor growth.

In experiments involving rhabdoid tumors and tumor cell lines, the Einstein scientists showed for the first time that Aurora A is highly expressed in both human and mouse rhabdoid tumors, that the loss of the INI1/hSNF5 tumor suppressor gene from rhabdoid tumor cells leads to the "de-repression" of Aurora A, and that knocking down Aurora A's expression in rhabdoid tumor cells potently inhibits the growth of those cells.

"Our findings indicate that targeti
'/>"/>

Contact: Kim Newman
sciencenews@einstein.yu.edu
718-430-3101
Albert Einstein College of Medicine
Source:Eurekalert

Page: 1 2

Related biology news :

1. Albert Einstein College of Medicine geneticist wins Sloan Research Fellowship
2. Einstein researcher receives American Cancer Society Medal of Honor
3. Einstein receives $30 million to study protein form and function
4. Einstein designated an NIH Center of Excellence for aging research
5. Einstein receives $4 million to test HPV microbicide
6. Einstein researcher awarded prestigious cancer research grant
7. Einstein-Montefiore research tackles childhood obesity in the Bronx
8. Einstein researchers discover 2 new ways to kill TB
9. Einstein receives high-risk/high-reward cancer research funding
10. Einstein to develop anti-HIV drug delivery system
11. Einstein scientists move closer to a safer anthrax vaccine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/30/2015)... , June 30, 2015 Genisphere ... company as CEO to help further develop Genisphere,s therapeutics ... of partnering experience, having spent much of the last ... Therakine, Amgen, Baxter Bioscience, and Johnson & Johnson. Tom ... on Technology and Biotech Corporate Finance. He graduated from ...
(Date:6/26/2015)... Utah , June 26, 2015 ATL Technology, ... and devices with specialties in single use solutions, headquartered in ... of MedConx, Inc. (a California corporation ... and San Jose, Costa Rica ). ... Costa Rica with ATL Technology,s existing facility ...
(Date:6/25/2015)... LAKE CITY , June 25, 2015  Imagine ... first steps toward a healthier, happier life. That,s exactly ... is designed to do. The cutting-edge, portable health program ... offers real-life solutions to help improve your lifestyle and ... Association awards dinner and gala Wednesday night, USANA,s THA ...
Breaking Biology News(10 mins):Genisphere Appoints New CEO, Thomas Bliss 2Genisphere Appoints New CEO, Thomas Bliss 3ATL Technology Announces Acquisition of MedConx, Inc. and Expanded Global Footprint 2@USANAinc's Personalized Nutrition Program Wins Industry Innovation Award 2
... of the ,neglected tropical diseases, left aside by big pharma ... regions. But then more attention has to be paid to ... the World Health Organization urgently need to be changed. So ... based on ten years of research in Congo. The ...
... of damselfish, Stegastes nigricans , selectively weed the ... encourage the growth of their preferred algal species of ... Researchers writing in the open access journal BMC ... and explore their diverse gardening systems across the Indo-West ...
... circuits in newborn mice take around two weeks to become ... adds to understanding of the cold sensing protein TRPM8 (pronounced ... 2002 by David McKemy of the University of Southern California. ... the cold sensing circuit starts to develop in utero but ...
Cached Biology News:WHO guidelines on Buruli ulcer need adjustment 2When do newborns first feel cold? 2
(Date:7/29/2015)... /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ: AEZS ) ... optimized Erk inhibitor molecule for development, thus achieving ... new class of potential cancer therapies. ... for therapeutic intervention in cancer. Recently approved compounds ... B-Raf and Mek inhibitors. Erk inhibitors may be ...
(Date:7/29/2015)... ... 29, 2015 , ... Costello served as Lead Levee Design Engineering Manager for ... County, Texas area from future storm surge flooding, such as occurred in Hurricane Ike ... alignment alternatives for providing protection, Costello also balanced socio-economic and environmental needs ...
(Date:7/28/2015)... July 29, 2015 A ... acquiring, rapidly developing and commercialising innovative medicines to ... Highly experienced management team; blue chip ...   Mereo BioPharma Group Ltd ("Mereo"), a recently-formed ... ( c. £76.5m), gross, from blue chip institutional investors ...
(Date:7/28/2015)... -- People with a common form of hearing loss ... profound improvements in their hearing and understanding of speech ... multicenter study led by specialists at NYU Langone Medical ... of print in the journal The Laryngoscope July 7, researchers ... the United States implanted hybrid cochlear ...
Breaking Biology Technology:Aeterna Zentaris Announces Optimized Erk Inhibitor Compounds For Further Development 2Aeterna Zentaris Announces Optimized Erk Inhibitor Compounds For Further Development 3Preventing Storm Surge Flooding in Houston 2Mereo BioPharma Announces Formal Launch of Company; Raises $119m (c.£76.5m) and Acquires Innovative Mid-Stage Clinical Product Portfolio From Leading Pharmaceutical Company 2Mereo BioPharma Announces Formal Launch of Company; Raises $119m (c.£76.5m) and Acquires Innovative Mid-Stage Clinical Product Portfolio From Leading Pharmaceutical Company 3Mereo BioPharma Announces Formal Launch of Company; Raises $119m (c.£76.5m) and Acquires Innovative Mid-Stage Clinical Product Portfolio From Leading Pharmaceutical Company 4Mereo BioPharma Announces Formal Launch of Company; Raises $119m (c.£76.5m) and Acquires Innovative Mid-Stage Clinical Product Portfolio From Leading Pharmaceutical Company 5Mereo BioPharma Announces Formal Launch of Company; Raises $119m (c.£76.5m) and Acquires Innovative Mid-Stage Clinical Product Portfolio From Leading Pharmaceutical Company 6Mereo BioPharma Announces Formal Launch of Company; Raises $119m (c.£76.5m) and Acquires Innovative Mid-Stage Clinical Product Portfolio From Leading Pharmaceutical Company 7Mereo BioPharma Announces Formal Launch of Company; Raises $119m (c.£76.5m) and Acquires Innovative Mid-Stage Clinical Product Portfolio From Leading Pharmaceutical Company 8Mereo BioPharma Announces Formal Launch of Company; Raises $119m (c.£76.5m) and Acquires Innovative Mid-Stage Clinical Product Portfolio From Leading Pharmaceutical Company 9Mereo BioPharma Announces Formal Launch of Company; Raises $119m (c.£76.5m) and Acquires Innovative Mid-Stage Clinical Product Portfolio From Leading Pharmaceutical Company 10Mereo BioPharma Announces Formal Launch of Company; Raises $119m (c.£76.5m) and Acquires Innovative Mid-Stage Clinical Product Portfolio From Leading Pharmaceutical Company 11Hybrid Cochlear Implants For Common Form Of Hearing Loss May Benefit Millions 2Hybrid Cochlear Implants For Common Form Of Hearing Loss May Benefit Millions 3
... Guam became a living laboratory for scientists as they ... listen for rhinoceros beetles. A grant from USDA IPM ... detection of insects, to travel to Guam to collaborate ... Eradication Project. The results of this research were recently ...
... Scientific publication Lab Manager Magazine has entered into a collaboration with ... able to serve their audiences of laboratory managers in industry, government ... ... Ontario (PRWEB) April 14, 2009 -- Lab Manager Magazine, one of ...
... Okla., April 14 Aaron,s Bridge presents Autism ... 13-14, 2009, at The Embassy Suites Hotel and ... The conference will feature seminars devoted to educating ... MD; Bryan Jepson, MD; Dan Rossignol, MD; and ...
Cached Biology Technology:Lab Manager Magazine and Association of Laboratory Managers (ALMA) Collaborate 2Defeat Autism Now!(R) Regional Conference to be Held in Oklahoma June 13-14, 2009 2
...
... a-Amylase is an enzyme that ... mixture of maltose, maltotriose, and dextrins. ... of the human body is of,clinical ... states including,pancreatitis and diabetes; plant and ...
... series of Class II Biological Safety ... certification to the world's highest safety ... the cabinets cannot be adjusted out ... low noise and arm rest ensure ...
... Fluoroskan Ascent FL ... fluorometric and luminometric measurement ... long list of advanced ... and Luminoskan Ascent. Fluoroskan ...
Biology Products: